Role of Oxidative Damage in Alzheimer's Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery
Alzheimer's disease (AD) is a neurodegenerative disorder accounting for over 50% of all dementia patients and representing a leading cause of death worldwide for the global ageing population. The lack of effective treatments for overt AD urges the discovery of biomarkers for early diagnosis, i....
Saved in:
Main Authors: | Francesca Romana Buccellato (Author), Marianna D'Anca (Author), Chiara Fenoglio (Author), Elio Scarpini (Author), Daniela Galimberti (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacological and Epigenetic Regulators of NLRP3 Inflammasome Activation in Alzheimer's Disease
by: Francesca La Rosa, et al.
Published: (2021) -
Disease-modifying drugs in Alzheimer's disease
by: Ghezzi L, et al.
Published: (2013) -
Drug discovery from Chinese medicine against neurodegeneration in Alzheimer's and vascular dementia
by: So Kwok-Fai, et al.
Published: (2011) -
Neurodegeneration and the pharmacotherapeutic aspect of Alzheimer's disease
by: Żaneta Binert-Kusztal, et al.
Published: (2021) -
Neurodegeneration with brain iron accumulation: update on pathogenic mechanisms.
by: Sonia eLevi, et al.
Published: (2014)